Orofacial clefts are the most common congenital malformations of the head
and neck region, and approximately three-quarters of these patients have some
form of cleft palate deformity. Cleft palate repair is generally performed in
children between 6 and 12 months of age. The goals of palate repair are to
minimize the occurrence of fistulas, establish a normal velopharyngeal
mechanism, and optimize facial growth. This Maintenance of Certification review
discusses the incidence and epidemiology associated with cleft palate deformity
and specifics associated with patient care, including analgesia, surgical repair
techniques, and complications associated with repair of the cleft palate.
After viewing this course, the participant should be able to:
- Describe the incidence of cleft palate and risk
factors associated with development of an orofacial cleft.
- Understand differences among several techniques to
repair clefts of both the hard and soft palates.
- Discuss risk factors for development of postoperative
fistulas, velopharyngeal insufficiency, and facial growth problems.
- Establish a treatment plan for individualized care of a cleft palate patient.
Albert Woo, MD
Plastic and Reconstruction Surgery® Editors:
Editor-in-Chief: Rod J. Rohrich, MD
Co-Editor: James M. Stuzin, MD
Section Editor: Donald H. Lalonde, MD
Patient Safety Credit: 0.5
Media: Journal Article, Video
Publish Date: 12/28/2016
Estimated time to complete this course: 1.0 hour
Directly provided by the American Society of Plastic Surgeons® (ASPS®)
The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.
Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. None of the authors have any relevant financial relationships or affiliations to disclose. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.
Return Policy for Downloaded and Viewable Products
Products which are downloaded or viewable after purchase may not be returned. By placing an order you are agreeing to the product return terms and conditions set forth by this site. ASPS Shop Return Policy
Product Code: 20905